Automated decision support system for differential immune marker diagnostics of leukaemia and lymphomas («Dif-L» DSS))
Automated decision support system for differential immune marker diagnostics of leukaemia and lymphomas («Dif-L» DSS))
Principal researchers: N. Novosiolova;O,Krasko
Key words: Dif-L, DSS, leukaemia, lymphoma;
Field of application: public healthcare, the State Scientific and Practical Centre of Pediatric Oncology, hematology and immunology, medical universities, the Belarusian Medical Academy of Post-Graduate Education, regional clinics, immunologic laboratories, medical institutions of the Ministry of Healthcare of the Republic of Belarus.
Brief description, main features: full-fledged and prompt analysis of immunophenotyping results, aimed at differential diagnostics of leukaemia and lymphomas, providing the validity of medical decisions.
Novelty: The product has no analogues in CIS countries. Basic types of leukaemia diagnostics accuracy is 99,2%. Subtypes of leukaemia diagnostics accuracy is to 88%. Standard analysis period is up to 1 minute. Heuristic analysis period is up to 10 minutes;
Degree of product availability: The system has been implemented into 8 medical and educational institutes of Ministry of Healthcare of the Republic of Belarus.
Cooperation: The contract for the provision of the right to use the “Dif-L” DSS could be signed under the legal Decree issued in February 13, 2013
The main advantages of product implementing: medical diagnostic efficiency growth, increasing the efficiency of medical staff labor, speeding-up the differential diagnostics.
Approximate cost: -
Contacts: academic secretary – Oleg V. Gorokh, tel.: 8 (017) 284-21-76; principal researcher – Natalia A. Novosiolova, tel.: 8 (017) 284-02-40.